Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 620

Results For "RAT"

7943 News Found

Free guide to Colorectal Cancer Screening now available in Hindi
Healthcare | March 28, 2022

Free guide to Colorectal Cancer Screening now available in Hindi

Colorectal Cancer Screening is now translated into multiple languages to help people worldwide understand why, when and how to screen for colorectal cancer


Vela Diagnostics launches NGS-based pan-cancer panels
Medical Device | March 28, 2022

Vela Diagnostics launches NGS-based pan-cancer panels

Vela Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options


Philips expands network of clinical partners for early diagnosis and treatment of lung cancer
Medical Device | March 28, 2022

Philips expands network of clinical partners for early diagnosis and treatment of lung cancer

Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases


Tata Capital Healthcare Fund II raises Rs 955 crore
News | March 28, 2022

Tata Capital Healthcare Fund II raises Rs 955 crore

The fund will take equity positions in India-focused healthcare and life sciences-related companies


New spesolimab data show promising results in patients with generalised pustular psoriasis flares
Biotech | March 28, 2022

New spesolimab data show promising results in patients with generalised pustular psoriasis flares

Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status


Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore
Hospitals | March 27, 2022

Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore

The MoU proposed investments in hospitals, pharmacies and laboratories in the state


Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis
Biotech | March 27, 2022

Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis

There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022


NMPA approves Hansizhuang, its first monoclonal antibody
Drug Approval | March 27, 2022

NMPA approves Hansizhuang, its first monoclonal antibody

It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry


NATHEALTH 8th annual summit in New Delhi from March 28-29.
News | March 26, 2022

NATHEALTH 8th annual summit in New Delhi from March 28-29.

More than 120 speakers and 5,000 delegates are expected to attend


RCSE partner with Rela Hospitals for  advanced surgical course
Hospitals | March 26, 2022

RCSE partner with Rela Hospitals for advanced surgical course

These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training